# Trade Mark Journal No.2026/034 21 August 2026

## WO0000001931458 (5)

Office of origin: United States of America

Date of International Registration:30 March 2026
Date of designation in the UK: 30 March 2026

The mark consists of a stylized diamond formed from overlapping red and blue quadrilaterals.

The mark contains the colours red and blue.

The mark consists of a stylized diamond formed from overlapping red and blue quadrilaterals.

International priority date claimed: 7 October 2025 (United States of America) (99431625)

Class 5
  Pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neuromuscular, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders.

Biohaven Therapeutics Ltd.

Representative: Monica Riva Talley STERNE KESSLER GOLDSTEIN & FOX PLLC, 1101 K ST NW,, 10TH FLOOR, WASHINGTON DC 20005, UNITED STATES OF AMERICA